These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 23994379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age.
    Martins C, Garly ML, Bale C, Rodrigues A, Njie-Jobe J, Benn CS, Whittle H, Aaby P.
    J Infect Dis; 2014 Sep 01; 210(5):693-700. PubMed ID: 24688075
    [Abstract] [Full Text] [Related]

  • 4. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
    Benn CS, Aaby P, Balé C, Olsen J, Michaelsen KF, George E, Whittle H.
    Lancet; 1997 Jul 12; 350(9071):101-5. PubMed ID: 9228962
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age.
    Jensen TG, Whittle H, Mordhorst CH, Pedersen IR, Thaarup J, Poulsen A, Sodemann M, Jakobsen M, Brink L, Gansted U.
    Vaccine; 1994 Aug 12; 12(11):1026-31. PubMed ID: 7975843
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal.
    Aaby P, Samb B, Simondon F, Knudsen K, Seck AM, Bennett J, Markowitz L, Whittle H.
    Trans R Soc Trop Med Hyg; 1996 Aug 12; 90(3):326-30. PubMed ID: 8758096
    [Abstract] [Full Text] [Related]

  • 10. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A, Sukhoo R, Cutts FT, Bennett JV.
    Vaccine; 2007 May 22; 25(21):4170-4. PubMed ID: 17408818
    [Abstract] [Full Text] [Related]

  • 11. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.
    Whittle HC, Campbell H, Rahman S, Armstrong JR.
    Lancet; 1990 Oct 27; 336(8722):1046-8. PubMed ID: 1977029
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
    Rogers S, Sanders RC, Alpers MP.
    J Trop Med Hyg; 1991 Apr 27; 94(2):88-91. PubMed ID: 2023293
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
    Dilraj A, Cutts FT, de Castro JF, Wheeler JG, Brown D, Roth C, Coovadia HM, Bennett JV.
    Lancet; 2000 Mar 04; 355(9206):798-803. PubMed ID: 10711928
    [Abstract] [Full Text] [Related]

  • 16. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
    Whittle H, Hanlon P, O'Neill K, Hanlon L, Marsh V, Jupp E, Aaby P.
    Lancet; 1988 Oct 08; 2(8615):811-4. PubMed ID: 2902264
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.